Sera Prognostics, Inc.
SERA- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001534969
In the last 90 days, Sera Prognostics, Inc. insiders filed 0 open-market purchases and 5 sales; 47 institutions reported holding it in 13F filings for Q2 2026, worth $31.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Sera Prognostics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 33 | 28 | −5 |
| Shares | 9.52M | 8.86M | −653.6K (−6.9%) |
| Value | $31.4M | $16.5M | −$14.9M (−47.4%) |
New holders (1)
Institutions that held Sera Prognostics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 4 | $7 | 0.00% |
Sold out (6)
Institutions that held Sera Prognostics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| EAM Investors, LLC | 387,193 | $1.28M |
| Riverview Capital Advisers, LLC | 102,731 | $338.5K |
| Resource Consulting Group Inc | 46,734 | $154.0K |
| Susquehanna International Group, LLP | 15,400 | $50.7K |
| Citadel Advisors LLC | 12,087 | $39.8K |
| Segall Bryant & Hamill, LLC | 10,000 | $33.0K |